# Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung

> **NCT00006483** · PHASE2 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 27 (actual)

## Conditions studied

- Kidney Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** sargramostim

## Key facts

- **NCT ID:** NCT00006483
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-10
- **Primary completion:** 2003-01
- **Final completion:** 2013-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2016-07-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006483, "Sargramostim in Treating Patients With Kidney Cancer That Has Spread to the Lung". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00006483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*